(NASDAQ: GEVO) Gevo's forecast annual revenue growth rate of 126.06% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 3.26%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.07%.
Gevo's revenue in 2025 is $16,915,000.On average, 2 Wall Street analysts forecast GEVO's revenue for 2025 to be $39,980,105,526, with the lowest GEVO revenue forecast at $38,955,773,315, and the highest GEVO revenue forecast at $41,004,437,738. On average, 2 Wall Street analysts forecast GEVO's revenue for 2026 to be $45,845,755,242, with the lowest GEVO revenue forecast at $44,054,671,434, and the highest GEVO revenue forecast at $47,636,839,050.
In 2027, GEVO is forecast to generate $46,822,165,478 in revenue, with the lowest revenue forecast at $42,015,591,406 and the highest revenue forecast at $51,628,739,551.